RFDA - ETF AI Analysis

Top Page

RiverFront Dynamic US Dividend Advantage ETF (RFDA)

Rating:72Outperform

Price Target:―

RFDA, the RiverFront Dynamic US Dividend Advantage ETF, has an overall rating that suggests it is a solid, but not flawless, dividend-focused fund supported by several high-quality blue-chip holdings. Strong contributors like Microsoft and Merck, with robust financial performance, attractive or fair valuations, and long-term growth drivers in areas like cloud, AI, and pharmaceuticals, help lift the fund’s quality. However, exposure to banks such as Citigroup and JPMorgan, which face issues like higher credit costs, debt levels, and some financial and technical challenges, along with sector risks in energy names like Phillips 66, introduce added risk and may have held the rating back, while the fund’s mix of financials, healthcare, and energy also means investors should be mindful of sector-specific volatility.

Positive Factors

Strong Recent Performance

The ETF has delivered solid gains so far this year and over the past few months, showing positive momentum.

Well-Known, Strong Top Holdings

Many of the largest positions, such as UnitedHealth, Johnson & Johnson, Nvidia, and Alphabet, have shown strong or steady performance, helping support the fund’s returns.

Broad Sector Diversification

Holdings are spread across many sectors, including financials, health care, technology, energy, and others, which helps reduce the impact if one industry struggles.

Negative Factors

Higher Expense Ratio

The fund’s expense ratio is on the higher side for an ETF, which means more of your returns go toward fees each year.

Heavy U.S. Concentration

With almost all assets in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. economy.

Mixed Performance Among Top Tech Names

While some technology holdings like Nvidia have done well, others such as Microsoft have shown weaker recent performance, which can create uneven results within the portfolio.

RFDA vs. SPDR S&P 500 ETF (SPY)

AUM82.43M

RegionNorth America

Expense Ratio0.52%

Beta0.82

IssuerALPS

Inception DateJun 06, 2016

Dividend Yield1.85%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume1,682

30 Day Avg. Volume3,583

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

82.60

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering76

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

RFDA Summary

RFDA is the RiverFront Dynamic US Dividend Advantage ETF, focused on the overall U.S. stock market with an emphasis on companies that pay dividends. It doesn’t track a fixed index, but instead actively shifts its holdings across many sectors like financials, health care, and technology. Well-known companies in the fund include Microsoft, Apple, UnitedHealth, and JPMorgan Chase. An investor might choose RFDA for a mix of growth potential and regular dividend income in one diversified investment. A key risk is that its stock holdings can rise or fall with the broader U.S. market, and active management decisions may not always perform well.

How much will it cost me?The RiverFront Dynamic US Dividend Advantage ETF (RFDA) has an expense ratio of 0.52%, meaning you’ll pay $5.20 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, which involves more frequent adjustments to the portfolio to respond to market trends. Active management typically comes with higher costs compared to passively managed funds that track an index.

What would affect this ETF?The RiverFront Dynamic US Dividend Advantage ETF (RFDA) could benefit from growth in the technology sector, which makes up a significant portion of its holdings, especially with companies like Nvidia, Microsoft, and Apple driving innovation. However, rising interest rates or economic slowdowns could negatively impact dividend-paying stocks and sectors like financials and consumer cyclical, which are also key components of the ETF. Additionally, regulatory changes affecting large-cap tech companies may pose risks to its top holdings.

RFDA Top 10 Holdings

RFDA leans heavily into U.S. dividend stalwarts, with health care, financials, and energy doing much of the heavy lifting. Merck and Johnson & Johnson have been steady climbers, giving the fund a solid defensive backbone, while UnitedHealth’s more mixed path adds a bit of wobble to that story. On the financial side, JPMorgan and Citigroup are rising but not sprinting, offering support rather than fireworks. Tech is a smaller but important slice: Microsoft and Nvidia bring growth flair, though Nvidia’s recent choppiness means it’s no longer the undisputed engine of returns.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NVDA	Nvidia	3.34%	$2.77M	$5.55T	32.19%	76 Outperform
JNJ	Johnson & Johnson	3.26%	$2.71M	$663.28B	55.53%	78 Outperform
JPM	JPMorgan Chase	3.08%	$2.55M	$953.33B	18.69%	72 Outperform
UNH	UnitedHealth	2.84%	$2.36M	$356.47B	14.15%	72 Outperform
C	Citigroup	2.66%	$2.21M	$231.02B	43.65%	68 Neutral
COP	Conocophillips	2.50%	$2.08M	$161.29B	46.16%	78 Outperform
MSFT	Microsoft	2.50%	$2.07M	$3.71T	-0.89%	79 Outperform
PSX	Phillips 66	2.44%	$2.02M	$101.79B	92.83%	73 Outperform
MRK	Merck & Company	2.31%	$1.92M	$370.89B	77.67%	80 Outperform
BMY	Bristol-Myers Squibb	2.01%	$1.67M	$136.49B	41.48%	78 Outperform

RFDA Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

72.52

Positive

100DMA

70.69

Positive

200DMA

66.93

Positive

Market Momentum

MACD

0.20

Positive

RSI

49.42

Neutral

STOCH

18.36

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RFDA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 73.64, equal to the 50-day MA of 72.52, and equal to the 200-day MA of 66.93, indicating a neutral trend. The MACD of 0.20 indicates Positive momentum. The RSI at 49.42 is Neutral, neither overbought nor oversold. The STOCH value of 18.36 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RFDA.

RFDA Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
RFDA	―	―	$82.43M	0.52%	72 Outperform
BAMD	―	―	$99.76M	0.89%	71 Outperform
STNC	―	―	$91.78M	0.85%	68 Neutral
SOVF	―	―	$91.00M	0.75%	70 Neutral
PFOE	―	―	$90.82M	0.59%	70 Outperform
YALL	―	―	$89.81M	0.65%	66 Neutral

Performance Comparison

RFDA

RiverFront Dynamic US Dividend Advantage ETF

73.15

12.55

20.71%

BAMD

Brookstone Dividend Stock ETF

―

STNC

Stance Equity ESG Large Cap Core ETF

―

SOVF

Sovereign's Capital Flourish Fund

―

PFOE

Pathfinder Focused Opportunities ETF

―

YALL

God Bless America ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents